IL4 and myeloid sarcoma: Increased levels of IL-4 can be found near active demyelinating lesions of MS patients, and is elevated in the serum of MS patients during acute disease (27, 28); thus providing a rationale for the downregulation of IL-4 observed in Akt3Nmf350 mice with enhanced Akt3 signaling.